ASH Review VIRTUAL 2020: Current Updates in Hematologic Diseases
M

ASH Update on HCT for AML: Are We Starting to Refer AML Patients Earlier in CR1? Can PTCy Overcome HLA Barriers in Haplo-Identical HCT?

By ASH Review VIRTUAL 2020: Current Updates in Hematologic Diseases FEATURING Muhammad Umair Mushtaq
By ASH Review VIRTUAL 2020: Current Updates in Hematologic Diseases FEATURING Muhammad Umair Mushtaq
49 views
March 8, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba

Related Videos

16:18

Masterclasses from the Wards

Masterclasses in Dermatology

S. Elman

322 views
08:18

Treatment Strategies for Hematocrit Control in PV

Insights from 2023 ASH Annual Meeting

A. Zhou

928 views
15:14

Safety Profile of Ruxolitinib in Patients With MF

Icahn School of Medicine at Mount Sinai

D. Tremblay

873 views
06:51

Prevalence and Prediction of Ruxolitinib Treatment Emergent Thromboc…

Insights from 2023 ASH Annual Meeting

D. Tremblay

433 views
13:04

Treatment-Related Quality of Life in MF

Winship Cancer Institute - Emory University

A. Hunter

287 views
37:12

Leukemia Tumor Board at the Tisch Cancer Institute at Mount Sinai: 6…

Tisch Cancer Institute at Mount Sinai

M. Metzger

119 views
16:25

Diagnosis and Goals of Therapy in PV

Northwestern Medicine Oncology and Hematology

B. Stein

822 views
09:27

MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…

ASH 2022 Conference Coverage

M. McMullin

1.2K views
10:49

Using Cytoreductive Therapy to Prevent Cardiovascular Events in Pati…

Monia Marchetti

403 views
51:20

Polycythemia Vera: Disease Overview, Treatment Landscape, and Curren…

Jerry Spivak

577 views
13:04

Symptomatic Profiles of Patients With Polycythemia Vera: Implication…

Alexander Coltoff

323 views
10:44

A Real-World Evaluation of the Association Between Elevated Blood Co…

Aaron Gerds

1.1K views
40:05

Leukemia Tumor Board at the Tisch Cancer Institute at Mount Sinai: M…

Tisch Cancer Institute at Mount Sinai

D. Tremblay, J. Mascarenhas, R. Sheppard, A. Shih, I. Sarami

109 views
10:27

Splenomegaly in Polycythemia Vera: Clinical Significance and Relatio…

Richard T. Silver

329 views
09:45

SOHO 2021 Next Questions in AML

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

H. Kantarjian

27 views
20:32

Malignancy Associated Hemophagocytic Lymphohistiocytosis: Diagnosis …

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

S. Kalayoglu Besisik

47 views
08:04

Cell Morphology in Acute Leukemias & Hematologic Malignancies: Diffe…

2nd SOHO Italian Conference

G. Zini

28 views
07:01

Allogeneic Transplantation & AML Outcomes: What Is the Role of HSCT …

ASH Review VIRTUAL 2020: Current Updates in Hematologic Diseases

M. Mushtaq

12 views
25:01

Review of Emerging Therapies and Top Trials in Hematologic Malignanc…

Indy Hematology Review

R. Birhiray

582 views
25:56

Inherited Predisposition to Myeloid Hematologic Malignancies: Why Do…

UChicago Annual Updates from ASH 2019

S. Feurstein

53 views
AUTOPLAY